Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients

Acta Pharmacologica Sinica

Volumn 32, Issue 11, 2011, Pages 1419-1423

  Zhang, Yi Fan ^a   Chen, Xiao Yan ^a   Dai, Xiao Jian ^a   Leng, Xi Sheng ^b   Zhong, Da Fang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

clinical pharmacokinetics; liver transplantation; modifi ed release; tacrolimus

Indexed keywords

TACROLIMUS;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHINESE; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; GRAFT RECIPIENT; HUMAN; IMMEDIATE RELEASE FORMULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODIFIED RELEASE FORMULATION; MULTICENTER STUDY; OPEN STUDY; PLASMA CONCENTRATION-TIME CURVE;

ADULT; AGED; CHINA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; YOUNG ADULT;

EID: 80755163124     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.125     Document Type: Article

References (18)

1. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 2004; 43: 623-53. (Pubitemid 38981845)
2. Gewirtz AT, Sitaraman SV. Tacrolimus Fujisawa. Curr Opin Investig Drugs 2002; 3: 1307-11.
3. Scott L, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003; 63: 1247-97. (Pubitemid 36750952)
4. Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 2009; 31: 139-52.
5. First MR, Fitzsimmons WE. Modifi ed release tacrolimus. Yonsei Med J 2004; 45: 1127-31.
6. Wente MN, Sauer P, Mehrabi A, Weitz J, Büchler MW, Schmidt J, et al. Review of the clinical experience with a modifi ed release form of tacrolimus [FK506E (MR4)] in transplantation. Clin Transplant 2006; 20: 80-4. (Pubitemid 44697905)
7. Chisholm MA, Middleton MD. Modified-release tacrolimus. Ann Pharmacother 2006; 40: 270-5. (Pubitemid 43269857)
8. First MR. First clinical experience with the new once-daily formulation of tacrolimus. Ther Drug Monit 2008; 30: 159-66. (Pubitemid 351521642)
9. Florman S, Alloway R, Kalayoglu M, Lake K, Bak T, Klain A, et al. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modifi ed release tacrolimusbased regimen. Transplant Proc 2005; 37: 1211-3. (Pubitemid 40590839)
10. Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, et al. Conversion of stable kidney transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. Transplant Proc 2005; 37: 867-70. (Pubitemid 40590728)
11. Alloway R, Vanhaecke J, Yonan N, White M, Haddad H, Rábago G et al. Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. J Heart Lung Transplant Epub 2011; 30: 1003-10.
12. Wlodarczyk Z, Squiffl et JP, Ostrowski M, Rigotti P, Stefoni S, Citterio F, et al. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, openlabel trial. Am J Transplant 2009; 9: 250513.
13. Fischer L, Trunecka P, Gridelli B, Roy A, Vitale A, Vajdivieso A, et al. Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open label trial. Liver Transplantation 2011; 17: 167-77.
14. Zhang YF, Chen XY, Dai XJ, Ao JH, Zhong DF. Comparison of pharmacokinetics of tacrolimus in Chinese de novo kidney transplant patients after repeated-dose of modified release tacrolimus and immediate release tacrolimus. Chin J Clin Pharmacol 2011; 27: In press. Chinese.
15. Merli M, Di Menna S, Giusto M, Giannelli V, Lucidi C, Loria S, et al. Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. Transplant Proc 2010; 42: 1322-4.
16. Hougardy JM, Broeders N, Kianda M, Massart A, Madhoun P, Le Moine A, et al. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. Transplantation 2011; 91: 566-9.
17. Marzoa-Rivas R, Paniagua-Martín MJ, Barge-Caballero E, Pedrosa del Moral V, Barge-Caballero G, Grille-Cancela Z, et al. Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. Transplant Proc 2010; 42: 2994-6.
18. Li GM, Zheng SS, Liu YF, Zhu ZJ, Xia Q, Zhou J, et al. A randomized trial on the effi cacy and safety of Advagraf vs tacrolimus in prevention of acute liver allograft rejection. Chin J Organ Transplant 2011; 32: 217-20.